Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Im Cannabis | IMCC | Sep 19, 2024 | 2.15 | -4.02 |
IMAC | BACK | Sep 19, 2024 | 1.38 | 0.00 |
IMAX | IMAX | Sep 19, 2024 | 20.29 | -0.15 |
Immatics | IMTX | Sep 19, 2024 | 12.16 | -0.25 |
Immersion | IMMR | Sep 19, 2024 | 8.89 | +1.25 |
Immix Biopharma | IMMX | Sep 19, 2024 | 1.77 | -0.56 |
ImmuCell | ICCC | Sep 19, 2024 | 3.63 | +0.83 |
Immuneering A | IMRX | Sep 19, 2024 | 2.42 | +6.14 |
Immunic | IMUX | Sep 19, 2024 | 1.95 | +8.94 |
ImmunityBio | IBRX | Sep 19, 2024 | 3.48 | +1.75 |
Immunocore ADR | IMCR | Sep 19, 2024 | 34.21 | -0.67 |
Immunome | IMNM | Sep 19, 2024 | 15.29 | -1.35 |
ImmunoPrecise Antibodies | IPA | Sep 19, 2024 | 0.68 | +2.27 |
Immunovant | IMVT | Sep 19, 2024 | 29.59 | +2.39 |
Immutep ADR | IMMP | Sep 19, 2024 | 2.25 | +0.90 |
Imperial Oil | IMO | Sep 19, 2024 | 68.87 | +2.88 |
Imperial Petroleum | IMPP | Sep 19, 2024 | 4.07 | +3.56 |
Imperial Petroleum A Pref | IMPPP | Sep 19, 2024 | 25.45 | -0.20 |
Impinj | PI | Sep 19, 2024 | 201.41 | +3.87 |
Imunon | IMNN | Sep 19, 2024 | 1.07 | -6.14 |
IN8bio | INAB | Sep 19, 2024 | 0.32 | -2.70 |
Inari Medical | NARI | Sep 19, 2024 | 43.84 | -1.22 |
Incannex Healthcare ADR | IXHL | Sep 19, 2024 | 1.90 | +3.26 |
Inception Growth Acquisition | IGTA | Sep 19, 2024 | 11.31 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Sep 19, 2024 | 11.69 | -3.55 |
Income Opportunity Realty Investors | IOR | Sep 19, 2024 | 17.00 | 0.00 |
Incyte | INCY | Sep 19, 2024 | 66.82 | +2.53 |
Indaptus Therapeutics | INDP | Sep 19, 2024 | 1.50 | +6.38 |
Independence Contract Drilling | ICD | Sep 19, 2024 | 0.65 | 0.00 |
Independence Realty Trust | IRT | Sep 19, 2024 | 21.12 | +1.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.